Forskaren’s Post

🚀 Yesterday at 'The Summit' event by FTI Gent, our CEO Hans Danneels delivered a powerful message about Flanders' potential in global #HealthTech innovation. Innovation in healthcare demands a balanced approach. It's about building on systems we know and trust, but also about embracing innovations that can truly redefine patient care. At Byteflies, this philosophy shapes our every endeavor. From streamlining established processes in cardiology to transformative solutions in neurology, we embody the spirit of versatile innovation. As Hans stated, trust and bold leadership will solidify Flanders' position at the pinnacle of technological innovation. Let's unite in this mission to push boundaries and lead change. 🔗 Want to innovate in telemonitoring? We can help. Discover how: https://lnkd.in/eyMa4Gv8 #FTIGent #HealthcareInnovation #Byteflies #Telemonitoring

INVITATION - How can healthcare systems become more equitable? ➡ UCD Lochlann Quinn School of Business ➡ 2nd & 3rd May ➡ All welcome The MISFIRES Conference 'Targeted Therapies' and accompanying art exhibition 'Chronic Illness: A Creative Exploration Art' will explore how to make healthcare systems more equitable by improving stakeholder input into biomedical and public health issues. The conference brings together some of the world’s top social scientists in healthcare, together with healthcare advocates and experts. “In simple terms, the conference will address the question of how society should deal with new therapeutic advances. Given the increase in medications that come onto the market at price points far beyond a million Euro per patient, these debates are now vital to hold,” said Professor Susi Geiger, UCD College of Business, who is organising the conference. Chronic Illness: A Creative Exploration Art Exhibition  An accompanying art exhibition displaying artwork done by people living with energy-limiting illnesses (ME/CFS and Long Covid) will launch on May 2nd at 2 pm where Julia Corey, a spokesperson from Long Covid Ireland, will open the exhibition. ➡ More information and to register: https://lnkd.in/ddynsTdR

Listening to all the other inspiring presentations at FTI Gent's 'The Summit' reinforced my belief in Flanders' potential to be the global leader in technological innovation, but... Being a leader in innovation is challenging, especially in healthcare. More than any other sector, we need to innovate responsibly. But if we want to be a leader, we need a more balanced approach to innovation. Of course we need to continue building on the systems we know and trust. We also need to recognise that we're facing some serious challenges that won't be solved through incremental improvements alone - and innovate accordingly. At Byteflies our approach to innovation is a prime example of this. In cardiology, our solutions streamline established processes, making a lot of people's lives more comfortable. In neurology, our solutions are novel for most care providers, but can be life-altering for people with epilepsy. Small steps add up, but big leaps transform. Flanders is home to many visionary companies with cutting-edge technology, built by some of the brightest minds in the world. For us to realize our potential and cement ourselves as a world leader in technological innovation, we need all stakeholders to take a collective leap of faith. We must dare to trust, dare to lead. Let’s take the leap together. https://lnkd.in/etBZ8bZ6 #FTIgent #healthcareinnovation #innovation Wintercircus Ghent

Have you ever considered participating in a clinical trial but are worried about accessibility or understanding the guidelines? Good news! Many research studies now offer virtual engagement options and local testing facilities. Plus, before joining, you’ll receive clear guidelines for informed decision-making. Check out this article debunking myths about clinical trial participation: https://lnkd.in/g5dbfNK9 #WorldBronchiectasisDay2024 #WorldBronchiectasisDay #BronchiectasisResearch #bronchiectasis World Bronchiectasis Day is July 1, you can help spread awareness of bronchiectasis by sharing this post!

🌟 Insights from Meeting on the Med 2024! 🌟 This past week, CCRM Nordic delegates had the opportunity to immerse themselves in the evolving landscape of Regenerative medicine at the esteemed Meeting on the Med conference in Rome. It was a vibrant gathering of minds, buzzing with discussions on groundbreaking healthcare solutions. 🤝 Networking and Collaborations: It was exhilarating to meet potential clients, service providers, and suppliers from around the globe. The energy was palpable, and the possibilities for future collaborations are endless. Excited about what lies ahead! 🎤 Panel Discussions: A highlight was witnessing Jim Lund, CBDO at CCRM Nordic, participate in a riveting panel ‘Developing the ATMP Ecosystem of the Future’ that captivated the audience. 🔍 Key Topics Explored: Joint HTA/JCA Initiatives: A hot topic that sparked intense discussions on how harmonized technology assessments could revolutionize patients’ access of ATMPs. Allogenic ATMPs: While still challenging, the progress in cracking the complexities of allogeneic therapies was evident and remains a critical area of focus as it will hopefully allow for lowered COGS and shorter turnaround times. Patient-Centric Approaches: Hearteningly, patient welfare remains at the core of all discussions and innovations. The talk by @OPIE JONES FOUNDATION moved the audience and words from last year’s conference still echoed in participants' brains “These patients are either the first generation to live or the last one to die” which emphasizes the importance of Joint HTA/JCA Initiatives. We’re looking forward to translating these learnings into impactful solutions and partnerships! #CGMed24 #CCRMNordic #ATMP #JCA

In times of uncertainty, our determination to collaborate and aim to solve global unmet needs in healthcare serves as a beacon of hope and becomes our greatest strength. The first and foremost objective of Biomed Israel is to boost collaborations between the innovative HealthTech ecosystem in Israel and the global life science industry. Senior executives from multinationals, big pharma, medical devices, tech giants and international investors in the health industry come to Israel each May to "shop for" innovation in the field, in search for creative solutions, products and technologies, and the next big thing. The conference will highlight the best of what Israel has to offer in a variety of areas and indications that coincide with the current trends that are of interest to the global life science industry. Experts will engage in thought-provoking discussions and presentations addressing a broad set of themes, from novel biological disease models to the vast amounts of available data that need to be curated and analyzed to turn into knowledge. These will be further coupled with discussion about concerns regarding global standards of living and the rising cost of healthcare. Whether it’s chronic diseases, cognitive deficits, or cardiovascular and metabolic disorders, at this conference we will drill down to the interplay between specific trajectories and the therapeutic interventions designed to address them, both in terms of preventative measures and treatments. See you all next week at @ Biomed 2024

Discover how integrating patient insights can reshape clinical trials for better outcomes at SCOPE Europe when our colleague Roger takes part in a keynote panel. Learn more at https://lnkd.in/gqduWCh #SCOPEsummit #patientcentrictrials #patientengagement #patientrecruitment #clinicalresearch

🌟 West Swedish Life Science actors lead European initiative for precision medicine! 🌟 Sahlgrenska Science Park and Business Region Göteborg have taken leading roles in the prestigious PRECISEU project together with Region Västra Götaland and Sahlgrenska Universitetssjukhuset University Hospital. The mission is to connect innovation ecosystems across Europe to efficiently advance towards truly personalized healthcare. The PRECISEU project focuses on solving challenges in data management, business models, patient involvement, and ethical, legal, and social issues. Through this initiative, funded with a total of €22.7 million (half from Horizon Europe), the goal is to promote and accelerate the possibilities for truly personalised healthcare. "The project's focus on advanced therapies and health data integration is particularly exciting and promising for our region. This initiative, together with the establishment of CCRM This initiative alongside the establishment of CCRM Nordic in Gothenburg further solidifies Gothenburg's position as a leading hub for life science and health innovation," says Patrik Andersson, CEO of Business Region Göteborg. #Göteborg #Gothenburg #LifeScience #Precisionmedicine #Innovation #Healtcare #HorizonEurope https://lnkd.in/dpZKMzgh

🌟 Exciting News from Partnerskapskonferensen - elevating the landscape of clinical trials in the Stockholm region and Sweden 2024! 🌟 I had the privilege to share insights at the Partnerskapskonferensen 2024 on a critical topic - elevating the landscape of clinical trials in the Stockholm region and Sweden as a whole. Here's the essence of my message: 🔍 Driving Clinical Trial Advancement: A Strategic Approach 1️⃣ Introducing the Clinical Trialist Programme at Karolinska University Hospital: We're taking proactive steps to nurture talent and expertise through a specialized program aimed at ensuring a robust pipeline of skilled professionals dedicated to conducting clinical trials. This initiative at Karolinska University Hospital is a testament to our commitment to building sustainable capabilities. 2️⃣ Forging Strong Partnerships with Life science industry : Collaboration is key! By fostering strong relationships and trust with our healthcare industry partners, we're creating synergies that drive innovation and accelerate the pace of clinical research. Together, we're shaping the future of healthcare. 3️⃣ Embracing New Methodologies: Decentralized Clinical Trials (DCT) represent the future of clinical research. By embracing innovative approaches, we're enhancing accessibility, efficiency, and participant engagement, ultimately revolutionizing the trial experience. 4️⃣ Measuring Impact: It's not just about implementing strategies; it's about ensuring they deliver tangible results. We're committed to rigorous evaluation and measurement, continuously assessing our progress to ensure we're on the right track and that our efforts are yielding the intended outcomes. Join the Movement! Together, we have the power to transform the landscape of clinical trials, driving advancements that benefit patients, healthcare professionals, and society as a whole. Let's collaborate, innovate, and make a meaningful difference in healthcare. Reach out to learn more about how you can be a part of this exciting journey! #ClinicalTrials #InnovationInHealthcare #Partnerships #KarolinskaUniversityHospital #DCT #ImpactMeasurement #HealthcareRevolution Would love to hear your thoughts and engage in further discussion on this crucial topic! Let's drive change together. 🚀

Two new case studies are out! ✨ Learn more about these practical insights and examples on how collaboration between Philips and like-minded hospitals can make sustainable impact! 🍀 2/2: Champalimaud Foundation